<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>679</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15039340</PubmedId>
            <Abstract>The protective efficacy of Mycobacterium bovis BCG can be markedly augmented by stable integration of Mycobacterium tuberculosis genomic region RD1. BCG complemented with RD1 (BCG::RD1) encodes nine additional proteins. Among them, 10-kDa culture filtrate protein (CFP-10) and ESAT-6 (6-kDa early secreted antigenic target) are low-molecular-weight proteins that induce potent Th1 responses. Using pools of synthetic peptides, we have examined the potential immunogenicity of four other RD1 products (PE35, PPE68, Rv3878, and Rv3879c). PPE68, the protein encoded by rv3873, was the only one to elicit gamma interferon (IFN-gamma)-producing cells in C57BL/6 mice infected with M. tuberculosis. Anti-PPE68 T cells were predominantly raised against an epitope mapped in the N-terminal end of the protein. Importantly, inactivation of rv3873 in BCG::RD1 did not modify CFP-10 and ESAT-6 secretion. Moreover, the generation of IFN-gamma responses to these antigens following immunization with BCG::RD1 was independent of PPE68 expression. Taken together, these results show that PPE68 is an immunogenic product of the RD1 region, which does not interfere with the secretion and immunogenicity of CFP-10 and ESAT-6.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>2170-6</ArticlePages>
            <ArticleTitle>Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Demangel</LastName>
                    <ForeName>Caroline</ForeName>
                </Author>
                <Author>
                    <LastName>Brodin</LastName>
                    <ForeName>Priscille</ForeName>
                </Author>
                <Author>
                    <LastName>Cockle</LastName>
                    <ForeName>Paul J</ForeName>
                </Author>
                <Author>
                    <LastName>Brosch</LastName>
                    <ForeName>Roland</ForeName>
                </Author>
                <Author>
                    <LastName>Majlessi</LastName>
                    <ForeName>Laleh</ForeName>
                </Author>
                <Author>
                    <LastName>Leclerc</LastName>
                    <ForeName>Claude</ForeName>
                </Author>
                <Author>
                    <LastName>Cole</LastName>
                    <ForeName>Stewart T</ForeName>
                </Author>
            </Authors>
            <Affiliations>Unité de Génétique Moléculaire Bactérienne, Institut Pasteur, 75724 Paris Cedex 15, France. demangel@pasteur.fr.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;BCG Vaccine;Bacterial Proteins;CFP-10 protein, Mycobacterium tuberculosis;ESAT-6 protein, Mycobacterium tuberculosis;Epitopes, T-Lymphocyte;Immunodominant Epitopes;Interferon-gamma</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Bacterial(chemistry; immunology); BCG Vaccine(administration &amp; dosage; immunology); Bacterial Proteins(chemistry; immunology); Epitope Mapping; Epitopes, T-Lymphocyte; Female; Immunodominant Epitopes; Interferon-gamma(metabolism); Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Sequence Data; Mycobacterium tuberculosis(immunology; pathogenicity); Th1 Cells(immunology); Tuberculosis, Pulmonary(immunology; microbiology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>72</Volume>
                <Issue>4</Issue>
                <Title>Infection and immunity</Title>
                <Issn>0019-9567</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Pep3873</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ATNFFGINTIPIALTE</LinearSequence>
                        <StartingPosition>121</StartingPosition>
                        <EndingPosition>136</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>YP_178022.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2A</LocationOfData>
                <EpitopeId>5064</EpitopeId>
                <ReferenceStartingPosition>121</ReferenceStartingPosition>
                <ReferenceEndingPosition>136</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>6703</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>6 wo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>single injection into base of tail</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Cells were harvested 3 weeks post-immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>Pep3873</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATNFFGINTIPIALTE</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>136</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>YP_178022.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Authors state splenocytes were restimulated in vitro but methods indicate splenocytes were assayed directly ex-vivo using epitope to stimulate IFN-γ release.  As negative controls, untransfected M. bovis (BCG Pasteur strain) and H37Rv with an rv3873 knockout (containing PPE68 and six other potential antigens)  were used.  As a positive control, M. bovis transfected with the entire RD1 coding sequence was used.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

